🟢 Tiziana Life Sciences is trading 8.8% up in pre-market with no clear catalyst identified

Tiziana Life Sciences is trading at $1.10, up 8.84% in pre-market, with no clear company-specific catalyst identified.

• No company-specific announcement explaining the September 28 move surfaced in the search.
• The latest identified company news was September 21: the company completed final patient visits in its Phase 2a INFORM-MS trial, with topline data expected in October. That update does not establish the cause of the rise.
• Broader U.S. futures were lower, which also does not clearly explain the move.